Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/AKESO-INC-111325370/nieuws/Akeso-Inc-kondigt-aan-dat-een-Fase-III-studie-met-cadonilimab-in-combinatie-met-chemotherapie-als-45258067/?utm_source=whatsapp&utm_medium=social&utm_campaign=share